Ram Yegappan

Dr. Ram Yegappan

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Carbohydrate Polymers
Verified
Journal Article
Closed access
RYRam Yegappan
Ram Yegappan
VSVignesh Selvaprithiviraj
Vignesh Selvaprithiviraj
SASivashanmugam Amirthalingam
Sivashanmugam Amirthalingam
Jayakumar RangasamyJayakumar Rangasamy
Jayakumar Rangasamy

1 February 2019 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
RYRam Yegappan
Ram Yegappan
VSVignesh Selvaprithiviraj
Vignesh Selvaprithiviraj
SASivashanmugam Amirthalingam
Sivashanmugam Amirthalingam
AMAnnapoorna Mohandas
Annapoorna Mohandas
NHNathaniel S. Hwang
Nathaniel S. Hwang
Jayakumar RangasamyJayakumar Rangasamy
Jayakumar Rangasamy

1 May 2019 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
RYRam Yegappan
Ram Yegappan
VSVignesh Selvaprithiviraj
Vignesh Selvaprithiviraj
AMAnnapoorna Mohandas
Annapoorna Mohandas
Jayakumar RangasamyJayakumar Rangasamy
Jayakumar Rangasamy

19 October 2016 in Biomacromolecules
Verified
Journal Article
Closed access
FJFaraz Jivan
Faraz Jivan
RYRam Yegappan
Ram Yegappan
HPHannah Pearce
Hannah Pearce
JCJames K. Carrow
James K. Carrow
MMMichael McShane
Michael McShane
DADaniel L. Alge
Daniel L. Alge

13 December 2018 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
SMShiva Muthuswamy
Shiva Muthuswamy
AVAparna Viswanathan
Aparna Viswanathan
RYRam Yegappan
Ram Yegappan
VSVignesh Selvaprithiviraj
Vignesh Selvaprithiviraj
AVAnil Kumar Vasudevan
Anil Kumar Vasudevan
Jayakumar RangasamyJayakumar Rangasamy
Jayakumar Rangasamy

9 June 2022 in Advanced Healthcare Materials
Verified
Journal Article
Open access
RYRam Yegappan
Ram Yegappan
JLJan Lauko
Jan Lauko
ZWZhao Wang
Zhao Wang
Martin LavinMartin Lavin
Martin Lavin
AKAmanda w Kijas
Amanda w Kijas
ARAlan E Rowan
Alan E Rowan
Uncontrolled bleeding from traumatic injury remains the leading cause of preventable death with loss of balance between blood clotting (coagulation) and blood clot breakdown (fibrinolysis). A major limitation of existing hemostatic agents is that they require a functioning clotting system to control the bleeding and are largely based on gauze delivery scaffolds. Herein, a novel rapid wound sealant, composed of two recombinant snake venom proteins, the procoagulant ecarin, to rapidly initiate blood clotting and the antifibrinolytic textilinin, to prevent blood clot breakdown within a synthetic thermoresponsive hydrogel scaffold is developed. In vitro, it is demonstrated that clotting is rapidly initiated with only nanomolar concentrations of venom protein and clot breakdown is effectively inhibited by textilinin. A stable clot is formed within 60 s compared to normal clot formation in 8 min. In vivo studies reveal that the snake venom hydrogel rapidly controls warfarin‐induced bleeding, reducing the bleed volume from 48% to 12% and has demonstrated immune compatibility. A new class of hemostatic agents that achieve formation of rapid and stable blood clots even in the presence of blood thinners is demonstrated here.